Utilization of FibroScan in clinical practice
- PMID: 24452634
- DOI: 10.1007/s11894-014-0372-6
Utilization of FibroScan in clinical practice
Abstract
The evaluation of liver fibrosis is critical, particularly to rule out cirrhosis. Novel non-invasive tests such as transient ultrasound elastography are widely used to stage liver fibrosis as an alternative to liver biopsy, and this technology has recently been approved in the US. In this review, we discuss the performance characteristics of elastography for a variety of liver diseases and highlight practical appropriate suggestions for how to incorporate this technology into clinical practice.
Similar articles
-
Ultrasound Shear Wave Elastography for Liver Disease. A Critical Appraisal of the Many Actors on the Stage.Ultraschall Med. 2016 Feb;37(1):1-5. doi: 10.1055/s-0035-1567037. Epub 2016 Feb 12. Ultraschall Med. 2016. PMID: 26871407
-
Non-invasive score system for fibrosis in chronic hepatitis: proposal for a model based on biochemical, FibroScan and ultrasound data.Liver Int. 2015 Aug;35(8):2027-35. doi: 10.1111/liv.12761. Epub 2015 Jan 21. Liver Int. 2015. PMID: 25495478
-
Transient elastography in chronic viral hepatitis: a critical appraisal.Gut. 2011 Jun;60(6):759-64. doi: 10.1136/gut.2010.220863. Epub 2011 Mar 29. Gut. 2011. PMID: 21450696 Review. No abstract available.
-
Optimal Use of Transient Elastography and Acoustic Radiation Force Impulse to Stage Liver Fibrosis in HIV/HCV-Coinfected Patients in Clinical Practice.J Ultrasound Med. 2018 Jan;37(1):113-121. doi: 10.1002/jum.14312. Epub 2017 Jul 17. J Ultrasound Med. 2018. PMID: 28715086
-
Hepatic elastography for the assessment of liver fibrosis--present and future.Ultraschall Med. 2012 Dec;33(6):550-8. doi: 10.1055/s-0032-1313011. Epub 2012 Jul 25. Ultraschall Med. 2012. PMID: 22833202 Review.
Cited by
-
Non-Invasive Measurement of Hepatic Fibrosis by Transient Elastography: A Narrative Review.Viruses. 2023 Aug 13;15(8):1730. doi: 10.3390/v15081730. Viruses. 2023. PMID: 37632072 Free PMC article. Review.
-
Liver Fibrosis Regression and Associated Factors in HCV Patients Treated with Direct-Acting Antiviral Agents.Life (Basel). 2023 Sep 5;13(9):1872. doi: 10.3390/life13091872. Life (Basel). 2023. PMID: 37763276 Free PMC article.
-
The Largest American Study Comparing Transient Elastography and the Aminotransferase-to-platelet Ratio Index Score, Two Noninvasive Tests for Liver Fibrosis Staging in HIV/HCV Coinfected Patients.J Glob Infect Dis. 2019 Apr-Jun;11(2):80-82. doi: 10.4103/jgid.jgid_10_16. J Glob Infect Dis. 2019. PMID: 31198312 Free PMC article.
-
Prescribing a statin to a cirrhotic patient to reduce hepatic decompensation and improve survival: impossible you say?Dig Dis Sci. 2014 Aug;59(8):1684-7. doi: 10.1007/s10620-014-3228-x. Dig Dis Sci. 2014. PMID: 25008425 No abstract available.
-
Velacur ACE outperforms FibroScan CAP for diagnosis of MASLD.Hepatol Commun. 2024 Mar 22;8(4):e0402. doi: 10.1097/HC9.0000000000000402. eCollection 2024 Apr 1. Hepatol Commun. 2024. PMID: 38517204 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical